Activation of the somatotropic axis by testosterone in adult men: Evidence for a role of hypothalamic growth hormone-releasing hormone

Neuroendocrinology

Volumn 77, Issue 6, 2003, Pages 380-387

  Bondanelli, Marta ^a   Ambrosio, Maria Rosaria ^a   Margutti, Angelo ^a   Franceschetti, Paola ^a   Zatelli, Maria Chiara ^a   Degli Uberti, Ettore C ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

Clinical neuroendocrinology; Gonadal steroids; Growth hormone; Growth hormone releasing hormone; Insulin like growth factors; Somatostatin

Indexed keywords

ARGININE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HORMONE INHIBITOR; HYPOTHALAMUS HORMONE; SOMATOMEDIN C; TESTOSTERONE; TESTOSTERONE ENANTATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE ACTION; HORMONE INHIBITION; HORMONE RESPONSE; HORMONE SUBSTITUTION; HUMAN; HYPERGONADOTROPIC HYPOGONADISM; MALE; NEUROENDOCRINOLOGY; NEUROMODULATION; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL;

ADULT; AREA UNDER CURVE; ARGININE; CASE-CONTROL STUDIES; ESTRADIOL; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HEPTANOATES; HUMANS; HYPOGONADISM; HYPOTHALAMUS; IMMUNORADIOMETRIC ASSAY; INSULIN-LIKE GROWTH FACTOR I; MALE; PITUITARY GLAND; RADIOIMMUNOASSAY; SOMATOSTATIN; TESTOSTERONE;

EID: 0037964886     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071310     Document Type: Article

References (41)

1. Giustina A, Veldhuis JD: Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998;19:717-797.
2. Kerrigan JR, Rogol AD: The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence. Endocr Rev 1992;13:281-298.
3. Veldhuis JD, Evans WS, Shah N, Story S, Bray MJ, Anderson SM: Proposed mechanisms of sex-steroid hormone neuromodulation in the human GH-IGF-I axis; in Veldhuis JD, Giustina A (eds): Sex-Steroid Interactions with Growth Hormone. New York, Springer, 1999, pp 93-121.
4. Link K, Blizzard RM, Evans WS, Kaiser DL, Parker MW, Rogol AD: The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males. J Clin Endocrinol Metab 1986;62:159-164.
5. Liu L, Merriam GR, Sherins RJ: Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1987;64:651-656.
6. Ulloa-Aguirre A, Blizzard RM, Garcia-Rubi E, Rogol AD, Link K, Christie CM, Johnson ML, Veldhuis JD: Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab 1990;71:846-854.
7. Weissberger AJ, Ho KK: Activation of the somatotropic axis by testosterone in adult males: Evidence for the role of aromatization. J Clin Endocrinol Metab 1993;76:1407-1412.
8. Keenan BS, Richards GE, Ponder SW, Dallas JS, Nagamani M, Smith ER: Androgen-stimulated pubertal growth: The effects of testosterone and dihydrotestosterone on growth hormone and insulin-like growth factor I in the treatment of short stature and delayed puberty. J Clin Endocrinol Metab 1993;76:996-1001.
9. Eakman GD, Dallas JS, Ponder SW, Keenan BS: The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J Clin Endocrinol Metab 1996;81:1217-1223.
10. Giustina A, Scalvini T, Tassi C, Desenzani P, Poiesi C, Wehrenberg WB, Rogol AD, Veldhuis JD: Maturation of the regulation of growth hormone secretion in young males with hypogonadotropic hypogonadism pharmacologically exposed to progressive increments in serum testosterone. J Clin Endocrinol Metab 1997;82:1210-1219.
11. DiMartino-Nardi J, Wu R, Fishman K, Saenger P: The effect of long-acting analog of luteinizing hormone-releasing hormone on growth hormone secretory dynamics in children with precocious puberty. J Clin Endocrinol Metab 1991;73:902-926.
12. Harris DA, Van Vliet G, Egli CA, Grumbach MM, Kaplan SL, Styne DM, Vainsel M: Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing hormone-releasing hormone agonist. J Clin Endocrinol Metab 1985;61:152-159.
13. Martin LG, Clark JW, Connor TB: Growth hormone secretion enhanced by androgens. J Clin Endocrinol Metab 1968;28:425-428.
14. Gentili A, Mulligan T, Godschalk M, Clore J, Patrie J, Iranmanesh A, Veldhuis JD: Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men. J Clin Endocrinol Metab 2002;87:825-834.
15. Miki N, Ono M, Miyoshi H, Tsushima T, Shizume K: Hypothalamic growth hormone-releasing factor participates in the negative feedback regulation of growth hormone secretion. Life Sci 1989;44:469-476.
16. Sugihara H, Minami S, Wakabayashi I: Post-somatostatin rebound secretion of growth hormone is dependent on growth hormone-releasing factor in unrestrained female rats. J Endocrinol 1989;122:583-591.
17. Robinson IC, Jeffery S, Clark RG: Somatostatin and its physiological significance in regulating the episodic secretion of growth hormone in the rat. Acta Pediatr Scand Suppl 1990;367:87-92.
18. Cella SG, Luceri M, Cattaneo L, Torsello A, Muller EE: Somatostatin withdrawal as generator of pulsatile GH release in the dog: A possible tool to evaluate the endogenous GHRH tone? Neuroendocrinology 1996;63:481-488.
19. Rigamonti AE, Cavallera G, Bonomo S, Deghenghi R, Locatelli V, Cella SG, Muller EE: Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: Studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide. Eur J Endocrinol 2001;145:635-644.
20. Hindmarsh PC, Brain CE, Robinson IC, Matthews DR, Brook CG: The interaction of growth hormone-releasing hormone and somatostatin in the generation of a GH pulse in man. Clin Endocrinol (Oxf) 1991;35:353-360.
21. degli Uberti EC, Ambrosio MR, Cella SG, Margutti AR, Trasforini G, Rigamonti AE, Petrone E, Muller EE: Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man. J Clin Endocrinol Metab 1997;82:2885-2888.
22. Cappa M, Rigamonti AE, Bizzarri C, Porzio O, Civolani P, Cella SG, Loche S, Muller EE: Somatostatin infusion withdrawal: Studies in normal children and in children with growth hormone deficiency. J Clin Endocrinol Metab 1999;84:4426-4430.
23. Magnan E, Cataldi M, Guillaume V, Conte-Devolx B, Graziani N, Figaroli JC, Thomas F, Chihara K, Oliver C: Acute changes in growth hormone-releasing hormone secretion after injection of BIM 23014, a long-acting somatostatin analog, in rams. Life Sci 1992;51:831-838.
24. Fryburg DA, Weltman A, Jahn LA, Weltman JY, Samojlik E, Hintz RL, Veldhuis JD: Androgenic modulation of the growth Hormone-IGF axis and its impact on metabolic outcomes; in Veldhuis JD, Giustina A (eds): Sex-Steroid Interaction with Growth Hormone. New York, Springer, 1999, pp 82-92.
25. Veldhuis JD, Metzger DL, Martha PM Jr, Mauras N, Kerrigan JR, Keenan B, Rogol AD, Pincus SM: Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: Evidence from pubertal pathophysiology and sex-steroid hormone replacement. J Clin Endocrinol Metab 1997;82:3414-3420.
26. Andersen M, Hansen TT, Stoving RK, Bertelsen J, Hangaard J, Hyltoft Petersen P: The pyridostigmine-growth-hormone-releasing hormone test in adults. The reference interval and a comparison with the insulin tolerance test. Endocrinol Metab 1996;3:197-206.
27. Aimaretti G, Corneli G, Razzore P, Bellone S, Baffoni C, Arvat E: Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults. J Clin Endocrinol Metab 1998;83:1615-1618.
28. Ghigo E, Arvat E, Aimaretti G, Broglio F, Giordano R, Camanni F: Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. Baillieres Clin Endocrinol Metab 1998;12:341-358.
29. Valetto MR, Bellone J, Baffoni C, Savio P, Aimaretti G, Gianotti L: Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. Eur J Endocrinol 1996;135:135-138.
30. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Cammani F: Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996;81:3323-3327.
31. Brann DW: Glutamate: A major excitatory transmitter in neuroendocrine regulation. Neuroendocrinology 1995;61:213-225.
32. Fryburg DA, Weltman A, Jahn LA, Weltman JY, Samojlik E, Hintz RL, Veldhuis JD: Short-term modulation of the androgen milieu alters pulsatile, but not exercise- or growth hormone (GH)-releasing hormone-stimulated GH secretion in healthy men: Impact of gonadal steroid and GH secretory changes on metabolic outcomes. J Clin Endocrinol Metab 1997;82:3710-3719.
33. Del Rio G, Carani C, Velardo A, Zizzo G, Procopio M, Coletta F, Marrama P, Ghigo E: Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism. J Endocrinol Invest 1995;18:690-695.
34. Müller EE, Locatelli V, Cocchi D: Neuroendocrine control of growth hormone secretion. Physiol Rev 1999;79:511-607.
35. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD: Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Eur J Endocrinol 1998;139:59-71.
36. Iranmanesh A, Lizarralde G, Veldhuis JD: Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 1991;73:1081-1088.
37. Plotsky PM, Vale W: Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial-portal circulation of the rat. Science 1985;230:461-463.
38. Frohman LA, Downs TR, Clarke IJ, Thomas GB: Measurement of growth hormone-releasing hormone and somatostatin in hypothalamic-portal plasma of unanesthesized sheep. Spontaneous secretion and response to insulin-induced hypoglycemia. J Clin Invest 1990;86:17-24.
39. Lumpkin MD, Mulroney SE, Haramati A: Inhibition of pulsatile growth hormone (GH) secretion and somatic growth in immature rats with a synthetic GH-releasing factor antagonist. Endocrinology 1989;124:1154-1159.
40. Rizvi SS, Weinbauer GF, Arslan M, Partsch CJ, Nieschlag E: Testosterone modulates growth hormone secretion at the hypothalamic but not at the hypophyseal level in the adult male rhesus monkey. J Endocrinol 2000;165:337-344.
41. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam JR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO: Effect of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-58.